Revenue
$10.8M
Net Income
-$153.9M
▼ 761.6% YoY
EPS
-
Cash
$213.2M
▲ 513.2% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Fairmount Funds Management LLC | Buy | Jul 16, 2026 | 853.5K | $14.50 | $12.38M | Form 4 ↗ |
Lynch Ryan See Remarks | Sell | Jun 22, 2026 | 465 | $17.99 | $8K | Form 4 ↗ |
Pinkas Jan Chief Scientific Officer | Sell | Jun 22, 2026 | 1.3K | $17.99 | $23K | Form 4 ↗ |
Scalzo Richard William Chief Financial Officer | Sell | Jun 22, 2026 | 1.1K | $17.99 | $20K | Form 4 ↗ |
Bispham Barbara Harlin See Remarks | Sell | Jun 22, 2026 | 1.2K | $17.99 | $22K | Form 4 ↗ |
Im Ellie Eunkyung Chief Medical Officer | Sell | Jun 22, 2026 | 1.2K | $17.99 | $22K | Form 4 ↗ |
McNeill Jonathan President and COO | Sell | Jun 22, 2026 | 20.5K | $17.99 | $370K | Form 4 ↗ |
Brumm Joshua T Chief Executive Officer | Sell | Jun 22, 2026 | 42.3K | $17.99 | $761K | Form 4 ↗ |